anoro ellipta (previously anoro)
glaxosmithkline (ireland) limited - umeclidinium bromide, vilanterol trifenatate - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - anoro ellipta is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).
laventair ellipta (previously laventair)
glaxosmithkline (ireland) limited - umeclidinium bromide, vilanterol - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - laventair ellipta is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).
anoro ellipta 5522 mcg
glaxo smith kline (israel) ltd - umeclidinium as bromide; vilanterol as trifenatate - powder for inhalation - vilanterol as trifenatate 22 mcg; umeclidinium as bromide 55 mcg - vilanterol and umeclidinium bromide - anoro is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).anoro ellipta is not indicated for the relief of acute bronchospasm or for the treatment of asthma.
anoro ellipta powder
glaxosmithkline inc - vilanterol (vilanterol trifenatate); umeclidinium (umeclidinium bromide) - powder - 25mcg; 62.5mcg - vilanterol (vilanterol trifenatate) 25mcg; umeclidinium (umeclidinium bromide) 62.5mcg - antimuscarinics antispasmodics
anoro ellipta powder for inhalation
glaxo operations uk ltd - umeclidinium (umeclidinium bromide), vilanterol (vilanterol trifenatate) - powder for inhalation - 62.5mcg/dose+ 25mcg/dose
spiolto respimat
boehringer ingelheim israel ltd. - olodaterol as hydrochloride; tiotropium bromide as monohydrate - solution for inhalation - olodaterol as hydrochloride 2.5 mcg; tiotropium bromide as monohydrate 2.5 mcg - vilanterol and umeclidinium bromide - spiolto respimat is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).
anoro ellipta inhalation powder, pre-dispensed
glaxo saudi arabia, saudi arabia - vilanterol, umeclidinium bromide - inhalation powder, pre-dispensed - 25, 62.5 µg
anoro ellipta inhalation powder 62.5 mcg25 mcg
glaxosmithkline pte ltd - (umec strip) umeclidinium bromide (micronised) 74.2 mcg/dose eqv umeclidinium; (vi strip) vilanterol trifenatate (micronised) 40 mcg/dose eqv vilanterol - powder, metered - (umec strip) umeclidinium bromide (micronised) 74.2 mcg/dose eqv umeclidinium 62.5 mcg/dose; (vi strip) vilanterol trifenatate (micronised) 40 mcg/dose eqv vilanterol 25 mcg/dose
anoro ellipta 62.5mcg/25mcg 25 mcg, 62.5 mcg
مستودع أدوية سليمان طنوس وأولاده - suleiman tannous & sons co. ltd - vilanterol 25 mcg, umeclidinium 62.5 mcg - 25 mcg, 62.5 mcg
anoro ellipta inhalation powder, pre-dispensed
glaxo saudi arabia, saudi arabia - umeclidinium bromide,vilanterol - inhalation powder, pre-dispensed - 62.5,25 µg,